<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Healthcare</title>
    <link>https://www.globes.co.il/serveen/</link>
    <description>Keyword search for:</description>
    <copyright>Globes 2026</copyright>
    <language>en-us</language>
    <lastBuildDate>Sun, 13 Sep 2026 10:00:13 GMT</lastBuildDate>
    <ttl>10</ttl>
    <image>
      <height>40</height>
      <width>144</width>
      <link>https://www.globes.co.il/serveen/</link>
      <title>Israel's Business Arena</title>
      <url>https://www.globes.co.il/images/GlobesEN-144x40.gif</url>
    </image>
    <item>
      <title>After credit upgrade, Teva plans to recycle debt</title>
      <link>https://www.globes.co.il/en/article-1001554738</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001554738</guid>
      <description>The Israeli pharmaceutical company today reported its plan to issue senior notes, denominated in euros and US dollars.</description>
      <pubDate>Mon, 07 Sep 2026 17:54:52</pubDate>
    </item>
    <item>
      <title>New initiative seeks $500m to commercialize Israeli life science</title>
      <link>https://www.globes.co.il/en/article-1001554653</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001554653</guid>
      <description>Former Bristol Myers Squibb executive Samuel Moed and Compugen chairperson Dr. Anat Cohen-Dayag are leading the Israel National Biotech Innovation Center.</description>
      <pubDate>Mon, 07 Sep 2026 19:17:02</pubDate>
    </item>
    <item>
      <title>Dramatic rise in doctors emigrating from Israel</title>
      <link>https://www.globes.co.il/en/article-1001554506</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001554506</guid>
      <description>1,300 doctors left Israel between 2023 and 2025, representing 3% of all the doctors employed in Israel, a new study by Tel Aviv University researchers has found.</description>
      <pubDate>Mon, 07 Sep 2026 09:34:56</pubDate>
    </item>
    <item>
      <title>Clalit to buy majority stake in Herzliya hospital</title>
      <link>https://www.globes.co.il/en/article-1001554492</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001554492</guid>
      <description>The Ministry of Health preferred that Clalit own over 50% of the hospital and vetoed private deals.</description>
      <pubDate>Sun, 06 Sep 2026 11:31:46</pubDate>
    </item>
    <item>
      <title>Teva drug meets endpoints in celiac disease trial</title>
      <link>https://www.globes.co.il/en/article-1001554296</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001554296</guid>
      <description>The antibody TEV &amp;lsquo;408 (anti-IL 15) was also tested as a treatment for the skin disease vitiligo, and there it also presented encouraging findings.</description>
      <pubDate>Thu, 03 Sep 2026 06:57:51</pubDate>
    </item>
    <item>
      <title>Teva share price hits nearly 10-year high</title>
      <link>https://www.globes.co.il/en/article-1001553109</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001553109</guid>
      <description>The Israeli pharmaceutical company&amp;rsquo;s stock has risen 20% over the past month.</description>
      <pubDate>Sun, 23 Aug 2026 15:48:58</pubDate>
    </item>
    <item>
      <title>Cancer treatment co UroGen invests $7m in Israel’s IntraGel</title>
      <link>https://www.globes.co.il/en/article-1001553029</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001553029</guid>
      <description>The advantage of InraGel's gel for treating cancer is that it can be injected and is biodegradable inside the body.</description>
      <pubDate>Thu, 20 Aug 2026 17:18:56</pubDate>
    </item>
    <item>
      <title>Israeli clinical trial simulation co QuantiHealth raises $45m</title>
      <link>https://www.globes.co.il/en/article-1001551282</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001551282</guid>
      <description>The company&amp;rsquo;s solutions allow life sciences enterprises to move away from designing clinical trials based on subjective assumptions toward launching trials that have been tested, optimized, and de-risked.</description>
      <pubDate>Tue, 04 Aug 2026 16:00:07</pubDate>
    </item>
    <item>
      <title>Branded drugs boost Teva revenue</title>
      <link>https://www.globes.co.il/en/article-1001550818</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001550818</guid>
      <description>The Israeli pharmaceutical company sees higher than expected sales of Austedo, Ajovy and Uzedy in 2026.</description>
      <pubDate>Wed, 29 Jul 2026 15:11:37</pubDate>
    </item>
    <item>
      <title>Entera Bio raises $275m for Phase III osteoporosis drug trial</title>
      <link>https://www.globes.co.il/en/article-1001550589</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001550589</guid>
      <description>The new funds from the private placement will finance the company until 2030.</description>
      <pubDate>Tue, 28 Jul 2026 12:01:53</pubDate>
    </item>
    <item>
      <title>NovoCure surges on Q2 results</title>
      <link>https://www.globes.co.il/en/article-1001550378</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001550378</guid>
      <description>The company, a developer of cancer treatments using electric fields, handily beat the analysts on the top and bottom line, and reported success with new products.</description>
      <pubDate>Thu, 23 Jul 2026 19:25:37</pubDate>
    </item>
    <item>
      <title>Kamada jumps on $50m source plasma deal</title>
      <link>https://www.globes.co.il/en/article-1001549876</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001549876</guid>
      <description>The new three-year agreement for the supply of normal source plasma from Kamada's plasma collection centers in Texas will produce about $50 million in revenue over three years.</description>
      <pubDate>Mon, 20 Jul 2026 15:42:49</pubDate>
    </item>
    <item>
      <title>Teva stock’s downward trend continues</title>
      <link>https://www.globes.co.il/en/article-1001549782</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001549782</guid>
      <description>Despite the recent losses, analyst Ori Hershkovitz sees a 31% upside in the Israeli pharmaceutical company&amp;rsquo;s share price.</description>
      <pubDate>Sun, 19 Jul 2026 14:52:41</pubDate>
    </item>
    <item>
      <title>Merck downsizing two Israeli development centers</title>
      <link>https://www.globes.co.il/en/article-1001549776</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001549776</guid>
      <description>The German company will implement layoffs in Jerusalem and Rehovot.</description>
      <pubDate>Sun, 19 Jul 2026 13:09:22</pubDate>
    </item>
    <item>
      <title>NeuroAI diagnostic co Hemispheric raises $52m</title>
      <link>https://www.globes.co.il/en/article-1001549435</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001549435</guid>
      <description>The Israeli company&amp;rsquo;s AI model can analyze brain activity measured by non-invasive means and turn it into quantitative metrics designed to help doctors and researchers make diagnoses.</description>
      <pubDate>Wed, 15 Jul 2026 16:37:05</pubDate>
    </item>
    <item>
      <title>Rafa offer for sale nets FIMI NIS 500m</title>
      <link>https://www.globes.co.il/en/article-1001549294</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001549294</guid>
      <description>Private equity firm FIMI bought control of pharmaceuticals company Rafa Laboratories from the Sackler family in 2020.</description>
      <pubDate>Tue, 14 Jul 2026 17:29:14</pubDate>
    </item>
    <item>
      <title>Rappaport vies with Tshuva for Herzliya hospital</title>
      <link>https://www.globes.co.il/en/article-1001549207</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001549207</guid>
      <description>Assaf Rappaport and the other Wiz founders seek to buy 25% of Herzliya Medical Center at a NIS 1 billion valuation, and a similar offer from Yitzhak Tshuva is still open, but regulation may thwart both contenders.</description>
      <pubDate>Tue, 14 Jul 2026 11:59:13</pubDate>
    </item>
    <item>
      <title>Teva reports positive skin treatment drug results</title>
      <link>https://www.globes.co.il/en/article-1001548604</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001548604</guid>
      <description>The Israeli company reported in the study that patients showed improvements in skin pigmentation with vitiligo.</description>
      <pubDate>Tue, 07 Jul 2026 17:56:40</pubDate>
    </item>
    <item>
      <title>Israel missing out on global life sciences recovery</title>
      <link>https://www.globes.co.il/en/article-1001547197</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001547197</guid>
      <description>IATI's annual report for 2025 portrays general stagnation in the Israeli industry. with one or two bright spots.</description>
      <pubDate>Mon, 29 Jun 2026 10:45:36</pubDate>
    </item>
    <item>
      <title>5 Converge Bio: Drug improvements within hours</title>
      <link>https://www.globes.co.il/en/article-1001545851</link>
      <guid isPermaLink="false">https://www.globes.co.il/document?did=1001545851</guid>
      <description>Since it was founded two years ago, Converge Bio has signed six deals in six weeks and with the aid of AI manages to improve drugs in record time.</description>
      <pubDate>Wed, 17 Jun 2026 18:16:38</pubDate>
    </item>
  </channel>
</rss>